Related Experiment Video
Updated: Dec 18, 2025

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Bing-Chuan Geng1,2, Kyoung-Han Choi2, Shan-Zhi Wang3
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
This study introduces a rapid, two-week method for genome editing in induced pluripotent stem cells (iPSCs) using CRISPR/Cas9. The approach minimizes Cas9 integration, preserving iPSC pluripotency and differentiation capabilities for disease research.
Area of Science:
- Biotechnology
- Genetics
- Stem Cell Biology
Background:
- Induced pluripotent stem cells (iPSCs) are crucial for disease modeling.
- CRISPR/Cas9 enables precise genome editing in mammalian cells.
- Current iPSC gene editing methods are inefficient and time-consuming.
Purpose of the Study:
- To develop a faster and more efficient method for genome editing in iPSCs.
- To minimize off-target effects and genomic integration of CRISPR/Cas9 components.
Main Methods:
- Electroporation-mediated delivery of plasmid-based CRISPR/Cas9.
- Utilizing transient introduction of the CRISPR/Cas9 machinery.
Main Results:
- An edited iPSC cell line was generated within two weeks.
- Minimized genomic integration of the Cas9 gene was achieved.
- Genome editing did not compromise iPSC pluripotency or differentiation potential.
Conclusions:
- The developed method significantly accelerates genome editing in iPSCs.
- This approach enhances the utility of iPSCs for disease research and therapeutic development.
- Transient CRISPR/Cas9 delivery offers a safer alternative by reducing long-term Cas9 expression side effects.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...

